Skip to content

AI
Chips
Space
Energy
Policy
Security
More
About
Contact

Search

Tag

PARP Inhibitors

Biotech

FDA Approves Pfizer’s Talzenna Combo for HRR-Mutated Metastatic Prostate Cancer

Pfizer’s PARP inhibitor plus enzalutamide is now approved for HRR-mutated metastatic prostate cancer before resistance sets in. In TALAPRO-3 it cut the…

Shocked Contributor

·

Oct 26, 2026

The future is arriving faster than anyone can process. Here’s what actually matters.

Edited by RJ. Stories bylined Shocked Contributor are written and published with AI assistance, under our editorial standards. Corrections.

Sections

AI
Chips & Hardware
Space
Energy
Biotech
Robotics

More

Consumer Tech
Policy
Security
General

Futureshock

About
Contact
Privacy
Start here
How we report
Corrections

© Futureshock · futureshock.wtf

Hype in. Signal out.

Hits